or
forgot password
  • cancer clinical trials in buffalo, NY

  • ChemoFx® PRO - A Post-Market Data Collection Study
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Uterine Neoplasms, Endometrial Cancer, Vaginal Cancer, Vulvar Cancer, Cervical Cancer
    Cognition in the Study of Tamoxifen and Raloxifene
    Roswell Park/Western New York STAR Consortium
    Buffalo, New York 14263
    Cognition, Aging
    A Study of ARRY-334543 and Capecitabine in Patients With Advanced Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Advanced Cancer
    Safety and Dose Determining Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Multiple Myeloma
    Erlotinib Hydrochloride With or Without Cixutumumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    RDEA119 and Sorafenib Combination Dose Escalation Study
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Advanced Cancer
    A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Patients With Advanced Carcinoma
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Advanced Carcinoma, Non-small Cell Lung Cancer
    Vaccine Therapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer
    A Study of BMS-863233 in Patients With Hematologic Cancer
    Roswell Park
    Buffalo, New York 14263
    Refractory Hematologic Cancer
    Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Kidney Cancer
    Radiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Head and Neck Cancer
    Collecting and Storing Tissue Samples From Patients With Head and Neck Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Head and Neck Cancer
    Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatment
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
    Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Advanced Non-hematologic Malignancies, Advanced Metastatic Melanoma
    Treatment Protocol of Velaglucerase Alfa for Patients With Type 1 Gaucher Disease
    Hemophilia Center of Western New York Incorporated
    Buffalo, New York 14215
    Gaucher Disease, Type 1
    Acceptability of Less Harmful Alternatives to Cigarettes
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Bladder Cancer, Cervical Cancer, Esophageal Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Leukemia, Liver Cancer, Lung Cancer, Pancreatic Cancer, Tobacco Use Disorder
    ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Prostate Cancer
    Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Pancreatic Cancer, Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    Dose Escalation Safety Study of TL32711 in Adults With Refractory Solid Tumors or Lymphoma
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Cancer
    Study of Lenalidomide in Combination With AT-101 for Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Lymphocytic Leukemia, Chronic B-Cell Leukemia
    Stage IV Surgery Versus Best Medical Therapy
    Buffalo General Hospital
    Buffalo, New York 14209
    Stage IV Resectable Melanoma
    Study of Lung Chemotherapy in the Treatment of Advanced Lung Cancer and Metastatic Sarcoma
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Lung Cancer, Sarcoma
    Alcohol Counseling for Telephone Quitline Callers
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Smoking, Nicotine Dependence, Alcohol Dependence
    Dose Escalation Study of Gemcitabine and ON 01910.Na in Solid Tumors
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Malignant Neoplasmas, Solid Tumors
    A Trial of Photodynamic Therapy With HPPH for Treatment of Dysplasia, Carcinoma in Situ and T1 Carcinoma of the Oral Cavity and/or Oropharynx
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Dysplasia, Carcinoma of the Oral Cavity, Carcinoma of the Oropharynx
    A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Head and Neck Cancer, Liver Cancer, Breast Cancer, Gastric Cancer, Non-Small Cell Lung Cancer
    Vitamin D and Breast Cancer Biomarkers in Female Patients
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Breast Cancer
    Exercise Intervention in Breast Cancer Patients With Treatment-Induced Arthralgia
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Breast Cancer, Arthralgia
    Study of Photodynamic Therapy (PDT) Using HPPH in Barrett's Esophagus
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Barrett's Esophagus, CIS, High Grade Dysplasia
    Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Lenalidomide in Treating Patients With High-Risk Chronic Lymphocytic Leukemia
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    B-cell Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    The Jewels in Our Genes Study - an African American Family Study of Breast Cancer
    University at Buffalo
    Buffalo, New York 14214-3007
    Breast Cancer
    Expanded Access Program of Ponatinib
    Roswell Park Cancer Institute, Site #029
    Buffalo, New York 14263
    Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
    Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Chemotherapeutic Agent Toxicity, Mucositis, Radiation Toxicity, Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Xerostomia
    Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage I Squamous Cell Carcinoma of the Oropharynx, Stage I Verrucous Carcinoma of the Oral Cavity, Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage II Squamous Cell Carcinoma of the Oropharynx, Stage II Verrucous Carcinoma of the Oral Cavity, Tongue Cancer
    Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Mucositis, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage III Verrucous Carcinoma of the Larynx, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IVA Squamous Cell Carcinoma of the Larynx, Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVA Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVA Verrucous Carcinoma of the Larynx, Stage IVA Verrucous Carcinoma of the Oral Cavity, Stage IVB Squamous Cell Carcinoma of the Larynx, Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVB Squamous Cell Carcinoma of the Oropharynx, Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVB Verrucous Carcinoma of the Larynx, Stage IVB Verrucous Carcinoma of the Oral Cavity, Stage IVC Squamous Cell Carcinoma of the Larynx, Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVC Squamous Cell Carcinoma of the Oropharynx, Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVC Verrucous Carcinoma of the Larynx, Stage IVC Verrucous Carcinoma of the Oral Cavity, Tongue Cancer
    Birinapant With 5-azacitidine in MDS Subjects Who Relapsed or Are Refractory to 5-azacitidine Therapy
    Tetralogic research site
    Buffalo, New York 14263
    Myelodysplastic Syndrome
    Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Bone Metastases, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation, Untreated Adult Acute Myeloid Leukemia
    Tivozanib in Treating Patients With Liver Cancer That is Metastatic or Cannot be Removed by Surgery
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Photodynamic Therapy During Surgery in Treating Patients With Non-Small Cell Lung Cancer That Can be Removed by Surgery
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Recurrent Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer
    Methods Project 4: Clinical Trial
    Roswell Park Cancer Center
    Buffalo, New York 14263
    Smoker
    Etirinotecan Pegol (NKTR 102) in Treating Patients With Relapsed Small Cell Lung Cancer
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Recurrent Small Cell Lung Cancer
    Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by Surgery
    Roswell Park Cancer Institute
    Buffalo, New York 14263
    Recurrent Melanoma, Stage IA Melanoma, Stage IB Melanoma, Stage IIA Melanoma, Stage IIB Melanoma, Stage IIC Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma